Viability Of Sulzer Inter-Op Proposed Class Action Settlement In Doubt
This article was originally published in The Gray Sheet
Executive Summary
A preliminary federal appeals court decision allowing individual Inter-Op hip shells and Natural Knee II implant lawsuits to proceed, combined with a sagging price in Sulzer Medica stock, may doom the firm's proposed $783 mil. class action settlement, forcing Sulzer to seek protection under federal bankruptcy laws